🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, open-label, phase I study designed to determine th...
Status
Terminated
Location
Froedtert & the Medical College of Wisconsin
Start Date
2022-10-31
Trial ID
NCT05325281
This Phase II study is conducted to assess the safety and efficacy of CPI-6...
Status
Withdrawn
Location
Eastchester Center for Cancer Care
Start Date
2014-01
Trial ID
NCT01830322
Treatments Being Tested
This pilot clinical trial studies 6,8-bis(benzylthio)octanoic acid in treat...
Status
Completed
Location
Comprehensive Cancer Center of Wake Forest University
Start Date
2013-07
Trial ID
NCT01839981
Treatments Being Tested
This phase I trial studies the side effects and best dose of CPI-613 when g...
Status
Completed
Location
Comprehensive Cancer Center of Wake Forest University
Start Date
2013-01
Trial ID
NCT01768897
Open label, randomized phase II study to evaluate efficacy and safety of CP...
Status
Withdrawn
Location
Hirschfeld Oncology
Start Date
2024-08-15
Trial ID
NCT06518538
Treatments Being Tested
This pilot phase I trial studies how well CPI-613 (6,8-bis\[benzylthio\]oct...
Status
Completed
Location
Comprehensive Cancer Center of Wake Forest University
Start Date
2015-09
Trial ID
NCT02484391
An open label, dose-escalation study to evaluate safety, tolerability, maxi...
Status
Completed
Location
Pivotal Research Centers
Start Date
2008-08
Trial ID
NCT00741403
Treatments Being Tested
The goal of this trial in Phase I is to determine the maximally tolerated d...
Status
Completed
Location
City of Hope
Start Date
2021-09-01
Trial ID
NCT04593758
Treatments Being Tested
This phase I trial studies the side effects and best dose of CPI-613 (6,8-b...
Status
Terminated
Location
Comprehensive Cancer Center of Wake Forest University
Start Date
2014-12
Trial ID
NCT02168907
This Phase II study is conducted to assess the safety and efficacy of CPI-6...
Status
Terminated
Location
Eastchester Center for Cancer Care
Start Date
2013-06
Trial ID
NCT01832857
Treatments Being Tested